Related Experiment Video

Updated: Apr 14, 2026

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
07:59

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products

Published on: October 4, 2019

10.5K

Targeting cancer with sesterterpenoids: the new potential antitumor drugs

Caiguo Zhang1, Yan Liu

  • 1Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, 80045, USA, caiguo.zhang@ucdenver.edu.

Journal of Natural Medicines
|April 21, 2015
PubMed

Insights

Sesterterpenoids, natural compounds from various organisms, show promise in inhibiting cancer cells. Further research is needed to understand their mechanisms and therapeutic potential in cancer treatment.

Area of Science:

  • Natural Product Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Cancer is a leading global cause of death, necessitating novel therapeutic strategies.
  • Chemotherapy relies on drugs targeting oncogenic pathways, with natural products being a significant source.
  • Sesterterpenoids, a class of natural molecules, have demonstrated in vitro anticancer activity, but their mechanisms remain unclear.

Purpose of the Study:

  • To review the functions of sesterterpenoids in inhibiting cancer cells.
  • To discuss the chemical structure-activity relationships of sesterterpenoids.
  • To highlight the importance of sesterterpenoids in cancer therapy.

Main Methods:

  • Literature review of studies on sesterterpenoids and their anticancer effects.
  • Analysis of chemical structures and their correlation with biological activity.
  • Synthesis of current knowledge on sesterterpenoid mechanisms in cancer.

Main Results:

  • Sesterterpenoids exhibit significant potential in inhibiting tumor cell growth in vitro.
  • Various sesterterpenoids derived from diverse natural sources show anticancer properties.
  • Structure-activity relationship studies provide insights into their anticancer potential.

Conclusions:

  • Sesterterpenoids represent a promising class of natural compounds for cancer therapy.
  • Understanding their molecular targets and mechanisms is crucial for drug development.
  • Further investigation into sesterterpenoids could lead to novel anticancer agents.

More Related Videos

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.9K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.4K
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
89
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
56.1K